Mackenzie Financial »

Rhythm Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $228k 4.3k 52.39

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Canadian Pacific Kansas City (CP)
Canadian Natl Ry (CNI)
Alphabet Cap Stk Cl A (GOOGL)
Canadian Natural Resources (CNQ)
NVIDIA Corporation (NVDA)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Amazon (AMZN)
Bk Nova Cad (BNS)
Sun Life Financial (SLF)

View all positions for Mackenzie Financial

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Perceptive Advisors
Vanguard Group
NEA Management Company
Frazier Life Sciences Management
State Street Corporation
Federated Investors
Driehaus Capital Management
Rock Springs Capital Management
Geode Capital Management

View all funds holding Rhythm Pharmaceuticals